Serum levels of soluble tumor necrosis factor-α receptor 2 are linked to insulin resistance and glucose intolerance in children

被引:26
作者
Gupta, A [1 ]
Ten, S [1 ]
Anhalt, H [1 ]
机构
[1] Maimonides Hosp, Div Pediat Endocrinol, Brooklyn, NY 11219 USA
关键词
obesity; OGTT; insulin; insulin sensitivity; HOMA; lipids;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Obesity and insulin resistance are increasingly common problems in children. Tumor necrosis factor-alpha (TNF-alpha) has important effects on lipid and glucose metabolism. This effect may be mediated through soluble TNF-alpha receptor 2 (sTNFR2). Objective: To investigate the relationship between insulin resistance and the TNF-alpha system in childhood obesity. Children and Methods: Twenty-one obese and six non-obese children were studied. Body mass index (BMI) z-scores, percent body fat (PBF) and waist to hip ratio (WHR) were determined. Fasting serum levels of total cholesterol, HDL-cholesterol, LDL-cholesterol, TNF-alpha and sTNFR2 were measured. A standard 2-hour oral glucose tolerance test (dose of glucose: 1.75 g/kg, max. 75 g) was done. Insulin resistance (IR) was estimated by fasting plasma insulin, plasma insulin at 120 min, homeostasis model assessment (HOMA) and insulin area under the curve (AUC) from OGTT. Insulin sensitivity was estimated by oral glucose insulin sensitivity (OGIS(120)). Results: Among the obese participants, one child (5.2%) was found to have diabetes mellitus and four others (21.1%) impaired glucose tolerance (IGT). Obese children had significantly elevated sTNFR2 levels. Furthermore, the group of obese children with IGT and the patient with newly diagnosed diabetes mellitus together (n = 5) had significantly higher levels of serum sTNFR2 (2,865 +/- 320 pg/ml) than the rest of the obese (2,460 +/- 352 pg/ml; p = 0.016) or lean (1,969 +/- 362 pg/ml; p = 0.014) children. Serum sTNFR2 levels correlated positively with insulin AUC, HOMA IR, fasting plasma insulin, plasma insulin at 120 min, total cholesterol and LDL/HDL ratio, and negatively with OGIS(120). Multiple regression analysis revealed that age. WHR, sTNFR2 and LDL predicted 81% of the variability in glucose at 120 min. Conclusion: sTNFR2 is a candidate marker of insulin resistance and glucose intolerance.
引用
收藏
页码:75 / 82
页数:8
相关论文
共 31 条
[1]   Effect of insulin on human aortic endothelial nitric oxide synthase [J].
Aljada, A ;
Dandona, P .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (02) :147-150
[2]   Insulin inhibits NFκB and MCP-1 expression in human aortic endothelial cells [J].
Aljada, A ;
Ghanim, H ;
Saadeh, R ;
Dandona, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :450-453
[3]   The tumor necrosis factor ligand and receptor families [J].
Bazzoni, F ;
Beutler, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1717-1725
[4]   The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm [J].
Dandona, P ;
Aljada, A ;
Mohanty, P .
DIABETOLOGIA, 2002, 45 (06) :924-930
[5]   Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age - The muscatine study [J].
Davis, PH ;
Dawson, JD ;
Riley, WA ;
Lauer, RM .
CIRCULATION, 2001, 104 (23) :2815-2819
[6]   Tumor necrosis factor receptor levels are associated with carotid atherosclerosis [J].
Elkind, MS ;
Cheng, JF ;
Boden-Albala, B ;
Rundek, T ;
Thomas, J ;
Chen, H ;
Rabbani, LE ;
Sacco, RL .
STROKE, 2002, 33 (01) :31-37
[7]  
Fernández-Real JM, 2000, DIABETES CARE, V23, P1714
[8]   Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance [J].
Fernández-Real, JM ;
Broch, M ;
Ricart, W ;
Casamitjana, R ;
Gutierrez, C ;
Vendrell, J ;
Richart, C .
DIABETES, 1998, 47 (11) :1757-1762
[9]   Polymorphism of the tumor necrosis factor-α receptor 2 gene is associated with obesity, leptin levels, and insulin resistance in young subjects and diet-treated type 2 diabetic patients [J].
Fernández-Real, JM ;
Vendrell, J ;
Ricart, W ;
Broch, M ;
Gutiérrez, C ;
Casamitjana, R ;
Oriola, J ;
Richart, C .
DIABETES CARE, 2000, 23 (06) :831-837
[10]  
Gavin JR, 2000, DIABETES CARE, V23, pS4